RCP
DXCM icon

Rothschild Capital Partners’s DexCom DXCM Stock Holding History

Rothschild Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,243
Closed -$2.6M – 30
2022
Q4 		$2.6M Buy
23,243
+7
+0% +$769 1.1% 28
2022
Q3 		$1.87M Hold
23,236
– – 0.86% 28
2022
Q2 		$1.73M Hold
23,236
– – 0.72% 28
2022
Q1 		$2.97M Sell
23,236
-992
-4% -$109K 1.04% 26
2021
Q4 		$3.25M Buy
24,228
+840
+4% +$121K 0.97% 29
2021
Q3 		$3.2M Buy
23,388
+100
+0.4% +$12.6K 1.02% 31
2021
Q2 		$2.49M Sell
23,288
-640
-3% -$61.5K 0.8% 34
2021
Q1 		$2.15M Sell
23,928
-12
-0.1% -$1.13K 0.73% 33
2020
Q4 		$2.21M Buy
23,940
+600
+3% +$53.6K 0.79% 33
2020
Q3 		$2.4M Hold
23,340
– – 0.95% 29
2020
Q2 		$2.37M Buy
23,340
+4,200
+22% +$376K 0.99% 27
2020
Q1 		$1.29M Buy
+19,140
New +$1.19M 0.72% 27
2017
Q3 		– Sell
-231,456
Closed -$4.23M – 52
2017
Q2 		$4.23M Hold
231,456
– – 1.61% 24
2017
Q1 		$4.9M Hold
231,456
– – 1.91% 21
2016
Q4 		$3.45M Sell
231,456
-32,740
-12% -$580K 1.47% 26
2016
Q3 		$5.79M Sell
264,196
-1,240
-0.5% -$27.6K 2.08% 19
2016
Q2 		$5.26M Sell
265,436
-7,032
-3% -$120K 2.03% 20
2016
Q1 		$4.63M Hold
272,468
– – 2.07% 20
2015
Q4 		$5.58M Hold
272,468
– – 2.81% 18
2015
Q3 		$5.85M Sell
272,468
-303,160
-53% -$6.76M 3.03% 13
2015
Q2 		$11.5M Sell
575,628
-285,792
-33% -$5.02M 4.96% 6
2015
Q1 		$13.4M Sell
861,420
-140,440
-14% -$2.12M 6% 3
2014
Q4 		$13.8M Buy
1,001,860
+16,400
+2% +$201K 6.63% 3
2014
Q3 		$9.85M Buy
985,460
+27,000
+3% +$276K 4.54% 6
2014
Q2 		$9.5M Buy
958,460
+19,360
+2% +$172K 4.28% 6
2014
Q1 		$9.71M Sell
939,100
-20,068
-2% -$207K 4.77% 6
2013
Q4 		$8.49M Hold
959,168
– – 3.99% 11
2013
Q3 		$6.77M Buy
959,168
+56,640
+6% +$359K 3.19% 15
2013
Q2 		$5.07M Buy
+902,528
New +$4.32M 2.82% 22

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rothschild Capital Partners's DXCM Position: Q1 2023 in Review

Rothschild Capital Partners sold out of DexCom (DXCM) in Q1 2023, closing a stake of 23,243 shares — an estimated $2.6M sold.

Rothschild Capital Partners first reported a position in DXCM in Q2 2013 and held it in 29 quarters. The position peaked at $13.8M in Q4 2014. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Rothschild Capital Partners reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Rothschild Capital Partners sold 23,243 DexCom shares in Q1 2023, an estimated $2.6M.
  • Rothschild Capital Partners first reported a position in DexCom in Q2 2013 and held it in 29 quarters.
  • Rothschild Capital Partners's DexCom position peaked at $13.8M in Q4 2014.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Rothschild Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.